Back to search
FDAFDA · Food and drugs·Recall number D-1021-2017

NORepinephrine Bitartrate 8 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0774-40

Published August 2, 2017 · Recall initiated: July 14, 2017

Summary

FDA records drug Class II recall D-1021-2017, published August 2, 2017 and initiated July 14, 2017. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: N/A; Lot: Lots: 20170502@31 BUD: 7/16/2017; 20170508@34 BUD: 7/22/2017; 20170508@70 BUD: 7/22/2017; 20170512@15 BUD: 7/26/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; product has the potential to leak.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals
Distributor
Nationwide
Lot
Lots: 20170502@31 BUD: 7/16/2017; 20170508@34 BUD: 7/22/2017; 20170508@70 BUD: 7/22/2017; 20170512@15 BUD: 7/26/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NORepinephrine Bitartrate 8 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0774-40 recalled?

Yes. FDA published recall D-1021-2017 on August 2, 2017. Reported hazard: Lack of Assurance of Sterility; product has the potential to leak.

What should I do if I have this product?

Voluntary: Firm initiated · Letter